Search

Your search keyword '"Nick Powell"' showing total 202 results

Search Constraints

Start Over You searched for: Author "Nick Powell" Remove constraint Author: "Nick Powell"
202 results on '"Nick Powell"'

Search Results

2. Defining predictors of responsiveness to advanced therapies in Crohn’s disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine

3. Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitis

4. Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23/IFNγ axis

5. Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy

6. CD90 is not constitutively expressed in functional innate lymphoid cells

7. The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patientsResearch in context

8. Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

9. Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsia

10. Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis

11. The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease

12. Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab

13. T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid Cells

14. Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?!

15. Automatic structural parcellation of mouse brain MRI using multi-atlas label fusion.

16. Surface-to-Space Atmospheric Waves From Hunga Tonga–Hunga Ha’apai Eruption

17. Microbiota-dependent expression of CTLA-4 by innate lymphoid cells restrains IFNγ dependent colitis

19. COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

20. The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease

21. COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study

22. Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research

23. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

24. Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine

25. Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel disease

26. The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients

28. High-resolution promoter interaction analysis in Type 3 Innate Lymphoid Cells implicates Batten Disease geneCLN3in Crohn’s Disease aetiology

29. Cognitive Impairment in Adult Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

30. Role of smoking in functional dyspepsia and irritable bowel syndrome: three random population‐based studies

36. The gut microbiota and metabolome is associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients

38. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study

39. S720 Endoscopic Severity Score of Immune-Mediated Colitis Is More Effective in Guiding Medical Treatment Than Clinical Severity Grade

40. Faecal calprotectin is a surrogate marker of biliary inflammation in primary sclerosing cholangitis associated inflammatory bowel disease

42. OP03 Anti-SARS-CoV2 antibody responses are attenuated in patients with Inflammatory Bowel Disease treated with infliximab

43. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic

44. Mechanisms of checkpoint inhibition-induced adverse events

45. Immune checkpoint inhibitor-induced colitis is mediated by CXCR6+ polyfunctional lymphocytes and is dependent on the IL23/IFNγ axis

46. A population of naive-like CD4(+) T cells stably polarized to the T(H)1 lineage

47. Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients

48. Neutralising Antibody Potency Against SARS-CoV-2 Ancestral and Omicron BA.1 and BA.4/5 Variants in Patients with Inflammatory Bowel Disease after Three Doses of COVID-19 Vaccine: A Prospective Multicentre Cohort Study (CLARITY)

49. COVID-19 Vaccine-Induced Antibody and T Cell Responses in Immunosuppressed Patients with Inflammatory Bowel Disease After the Third Vaccine Dose

50. Nature

Catalog

Books, media, physical & digital resources